Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. This is an Open Access article …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (COVID-19). This study aimed to determine if SARS-CoV-2 RNA …

Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

COVID-19 has overloaded national health services worldwide. Thus, early identification of
patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA …

Background This study aimed to clarify how SARS-CoV-2 RNAemia is related to COVID-19
critical condition development and mortality in comparison with other predictive markers and …

Background Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
RNA in blood, also known as RNAemia, has been reported, but its prognostic implications …

Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. All rights reserved. For …

Abstract Determinants of Post-Acute Sequelae of COVID-19 are not known. Here we show
that 83.3% of patients with viral RNA in blood (RNAemia) at presentation were symptomatic …

The clinical significance of SARS-CoV-2 RNA in the circulation is unknown. In this
prospective cohort study, we detected viral RNA in the plasma of 58/123 (47%) patients …

The disease spectrum of coronavirus disease 2019 (COVID‐19) varies from asymptomatic
infection to critical illness and death. Identification of prognostic markers is vital for predicting …